3

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: July 5, 2022
Period of Report: July 1, 2022
Accession Number: 0001104659-22-077471

View Document ↗ View on SEC.gov ↗